ZEPHYRx

The company’s FDA-cleared remote respiratory monitoring platform enables at-home pulmonary function testing with real-time data collection and video coaching. It has been deployed in clinical trials and healthcare practices for chronic lung diseases. Strategic partnerships have integrated the platform into major research studies and expanded its reach in decentralized clinical trials. Clinical results include increased patient compliance with respiratory therapy exercises—up to a reported twentyfold improvement—and successful integration into ALS natural history studies. The company’s technology supports both routine care and hybrid/decentralized clinical research.